Zacks Investment Research
John Vandermosten is a seasoned financial professional with extensive experience in equity research and analysis, particularly within the biotechnology and healthcare sectors. Currently serving as a Senior Biotechnology Analyst at Zacks Investment Research since March 2016, John specializes in publishing research on small-cap biotechnology firms, developing equity recommendations through comprehensive C-level interviews, and building investor relationships. Prior roles include Equity Analyst at Singular Research, Consultant at Coker Group, Portfolio Manager/Research Analyst at Westwood Holdings Group, and Portfolio Manager/Investment Analyst at the Teacher Retirement System of Texas. John's academic credentials include a Master's Degree in Economics/Business from Tulane University and a Bachelor's Degree from San Diego State University.
This person is not in any offices
Zacks Investment Research
In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com. For LinkedIN job seekers, Zacks.com is a good place to research prospective publicly traded employers for financial stability and growth prospects.